A popular drug prescribed to help people quit smoking may pose a significantly increased risk of heart attack in users, a new study finds. The results may further complicate doctors’ and patients’ ...

People who paid for a popular drug to quit smoking may be eligible for money in a major class action settlement with Pfizer. The $44 million settlement covers people and third parties who paid any ...

Pharmaceutical company Pfizer has agreed to a $44 million class action settlement over its oral prescription medication Chantix. Approved by the FDA in May 2006 as a smoking-cessation aid, the drug ...

Pfizer may be best known for its COVID-19 vaccine, but the pharmaceutical giant also made waves recently over a lesser-known drug social media users are claiming is unsafe. "FDA approval 2006, ...

For people with serious mental illness who are trying to quit smoking, extending their treatment with the smoking cessation drug Chantix (varenicline) may help them avoid a relapse, according to a new ...

(NEXSTAR) — Pfizer is voluntarily recalling the anti-smoking drug Chantix, a brand of varenicline, due to impurities that exceed approved levels, the Food and Drug Administration has announced. The ...

Impending copycat competition wasn’t unexpected given Chantix lost its main patent in November last year. (FDA) () Pfizer’s reign over the smoking treatment space with its cessation med Chantix is ...

When approved by the Food and Drug Administration in 2006, the prescription drug Chantix was heralded as almost a silver bullet in the fight to help people stop smoking. Its ingredient, varenicline, ...

Pfizer is voluntarily recalling all lots of its popular anti-smoking drug Chantix for high levels of nitrosamine, which can increase the risk of cancer. According to the notice posted on the Food and ...

And now it’s four times for Pfizer — the Chantix recall, that is. On Thursday, Sept. 16, Pfizer expanded its recall of Chantix 0.5 mg and 1 mg tablets to include all lots. In July and August, Pfizer ...